Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of cannabinoids on hyperalgesia in deep endometriosis
2018-004378-92Phase 2Active
- Sponsor
- Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cannabidiol and dronabinol in deep infiltrating endometriosis (DIE), endometriosis and hyperalgesia, sponsored by Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer. Primary endpoint: Pain threshold after mechanical stimulation in hypogastrium (anterior central L2 dermatome). Started Apr 2019; status: active.
02
Drugs
cannabidioldronabinol
03
Conditions
deep infiltrating endometriosis (DIE)endometriosishyperalgesia
Beyond the preview
Go deeper on 2018-004378-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004378-92.